<DOC>
	<DOCNO>NCT00124358</DOCNO>
	<brief_summary>The purpose study assess feasibility , cost effectiveness intervention design integrate buprenorphine treatment opioid dependence HIV primary care ten HIV care center U.S .</brief_summary>
	<brief_title>Buprenorphine Integrated HIV Care Evaluation</brief_title>
	<detailed_description>Programs integrate medical care drug treatment show great promise improve health substance use relate outcome . The overlap epidemic HIV ( complex medical need ) drug abuse make HIV-infected drug user population likely benefit integration primary care drug treatment . The Drug Addiction Treatment Act 2000 approval buprenorphine office-based treatment opioid addiction provide new opportunity integrate addiction treatment medical care people HIV . Research demonstrate effectiveness buprenorphine reduce illicit drug use among opioid dependent people . However , little known implement program HIV care setting , cost , effect health outcome substance use behavior PLWH/A , broad impact provider , institution , local system . Through study , approximately 1,350 HIV-infected individual meet criterion opioid dependence select eleven model demonstration project locate ten HIV care center across U.S. Information patient ’ drug use , HIV health status , service utilization , quality life , satisfaction service well information provider ’ practice attitude towards treat drug dependent patient collect face-to-face interview , audio computer-assisted self-interviewing , write survey , chart abstraction . These data use help replicate effective program integrate HIV care drug treatment improve care HIV-infected opioid dependent individual . Comparisons : All eleven program compare group patient receive integrated buprenorphine treatment HIV care group patient receive alternate intervention . However , program design comparison group intervention vary across site locally determine . Some site implement randomize control design , others use observational method .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>HIVinfected Clinical diagnosis opioid dependence Fluent English Spanish 18 year old Liver function test ( transaminase ) five time higher normal level ; Diagnostic Statistical Manual Mental DisordersFourth Edition ( DSMIV ) criteria benzodiazepine abuse dependence within past 6 month ; DSMIV criterion alcohol dependence within past 6 month ; Actively suicidal ; Psychiatric impairment impedes ability consent ( dementia , delusional , actively psychotic ) ; Methadone dose exceed level allow safe transition buprenorphine ; Pregnant woman woman actively try become pregnant ; Clinical judgment local site principal investigator patient inappropriate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Drug Abuse</keyword>
	<keyword>Drug Addiction</keyword>
	<keyword>Drug Dependence</keyword>
	<keyword>Drug Use Disorders</keyword>
	<keyword>Drug Use Disorder</keyword>
	<keyword>Substance Abuse</keyword>
	<keyword>Substance Use Disorder</keyword>
	<keyword>Buprenorphine</keyword>
	<keyword>Opiate Addiction</keyword>
	<keyword>Substance-related disorder</keyword>
	<keyword>HIV</keyword>
</DOC>